Cargando…

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis examined the optimal trough concentration of voriconazole for adult patients with invasive fungal infections. We used stepwise cutoffs of 0.5–2.0 μg/mL for efficacy and 3.0–6.0 μg/mL for safety. Studies were included if they reported the rates of all-cause mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanai, Yuki, Hamada, Yukihiro, Kimura, Toshimi, Matsumoto, Kazuaki, Takahashi, Yoshiko, Fujii, Satoshi, Nishizawa, Kenji, Miyazaki, Yoshitsugu, Takesue, Yoshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072959/ https://www.ncbi.nlm.nih.gov/pubmed/33923727 http://dx.doi.org/10.3390/jof7040306

Ejemplares similares

Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
por: Hanai, Yuki, et al.
Publicado: (2022)

The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
por: Tsutsuura, Moeko, et al.
Publicado: (2021)

1537. Multicenter Study with Therapeutic Drug Monitoring (TDM) of Voriconazole (VRCZ) in Japanese Patients
por: Ueda, Takashi, et al.
Publicado: (2019)

Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
por: Matsumoto, Kazuaki, et al.
Publicado: (2022)

Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan
por: Hamada, Yukihiro, et al.
Publicado: (2020)

Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
por: Hamada, Yukihiro, et al.
Publicado: (2013)

Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
por: Ueda, Takashi, et al.
Publicado: (2020)

The effect of inflammation on voriconazole trough concentrations in children
por: ter Avest, Mendy, et al.
Publicado: (2016)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
por: Zhao, Yi‐Chang, et al.
Publicado: (2020)

Moderate correlation between systemic IL‐6 responses and CRP with trough concentrations of voriconazole
por: Vreugdenhil, Bas, et al.
Publicado: (2018)

Remission of hepatotoxicity in chronic pulmonary aspergillosis patients after lowering trough concentration of voriconazole
por: Teng, Guo-Jie, et al.
Publicado: (2020)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
por: Jia, Su-jie, et al.
Publicado: (2021)

Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report
por: Kaneko, Hiromi, et al.
Publicado: (2022)

Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
por: Jin, Haiying, et al.
Publicado: (2016)

Association of Voriconazole Trough Plasma Concentration with Efficacy and Incidence of Hepatotoxicity in Iranian Patients with Hematological Malignancies
por: Taghvaye-masoumi, Hamidreza, et al.
Publicado: (2021)

Predictors of Voriconazole Trough Concentrations in Patients with Child–Pugh Class C Cirrhosis: A Prospective Study
por: Zhao, Yichang, et al.
Publicado: (2021)

Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data
por: Bolcato, Léa, et al.
Publicado: (2021)

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
por: Samura, Masaru, et al.
Publicado: (2022)

Generalized exfoliative skin rash as an early predictor of supratherapeutic voriconazole trough levels in a leukemic child: A case report
por: Amanati, Ali, et al.
Publicado: (2020)

Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole
por: Mafuru, Magesa, et al.
Publicado: (2021)

Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min
por: Yin, Ophelia, et al.
Publicado: (2021)

Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis
por: Liu, Xiaoxi, et al.
Publicado: (2022)

Of waves and troughs
por: Noll-Hussong, Michael
Publicado: (2014)

Validation of Vancomycin Area under the Concentration—Time Curve Estimation by the Bayesian Approach Using One-Point Samples for Predicting Clinical Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Infections
por: Ueda, Takashi, et al.
Publicado: (2022)

Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients
por: Jung, Hee-Yeon, et al.
Publicado: (2020)

Ropivacaine 0.025% mixed with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml is effective for epidural patient-controlled analgesia after cesarean section
por: Cohen, Shaul, et al.
Publicado: (2015)

Street Troughs and Glanders
Publicado: (1892)

Danger in the Water Trough
Publicado: (1885)

Prognostic impact of troponin > 0.2 μg/ml and < 0.5 μg/m in UA/NSTIMI
por: Gomes de Sá, S, et al.
Publicado: (2003)

Exploration of the optimal GS-441524 trough concentration for treating COVID-19
por: Nakano, Yuki, et al.
Publicado: (2023)

Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease
por: Kato, Masaichi, et al.
Publicado: (2021)

Response of chromoblastomycosis to voriconazole
por: de Lima, Alexandre Moretti, et al.
Publicado: (2016)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

Comparison of continuous epidural infusion of 0.125% ropivacaine with 1 μg/ml fentanyl versus 0.125% bupivacaine with 1 μg/ml fentanyl for postoperative analgesia in major abdominal surgery
por: Patil, Shruti Shrikant, et al.
Publicado: (2018)

1706. Use of Management Bundles as a Checklist for Candidemia: Impact of Compliance on Clinical Outcomes in a Multicenter Study in Japan
por: Ueda, Takashi, et al.
Publicado: (2019)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)

Colistin resistance screening by 3 μg/ml colistin agar in Carbapenemase‐producing Enterobacterales
por: Soria‐Segarra, Claudia, et al.
Publicado: (2022)

Invasive trichosporonosis treated with voriconazole
por: Garg, Vaibhav, et al.
Publicado: (2018)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_outd7ok47eip4uggengk42gidr